Company intelligence / Profile preview

ZSX Medical

King of Prussia, Pennsylvania, United Stateszsxmedical.com ↗

Ownership: Private
Development stage: Clinical

Overview

ZSX Medical has completed the first stage of its U.S. clinical study for Zip-stitch, with successful 6-week follow-up in the initial cohort. The company has received FDA IDE approval to begin a pivotal clinical study evaluating safety and efficacy. The technology aims to improve outcomes and reduce costs in minimally-invasive gynecological surgeries.

Therapeutic areas: OtherWomen's Health
Modalities: Device (Surgical closure system)
Industry: Surgical Medical Devices

Drug pipeline

1 asset

Zip-stitch

Clinical

Indications: Surgical closure, Vaginal cuff closure, Laparoscopic hysterectomy

Partnerships

Product development partners network

Beyond the preview

Go deeper on ZSX Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZSX Medical.

Explore the full profile